LONG-TERM FOLLOW-UP FROM THE PHASE 1/2 MAJESTEC-1 TRIAL OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS BY LINES OF THERAPIES
| Autor: | Costa, LJ, Donk, NWCJV, Rosinol, L, Popat, R, semer, Be, Martinez-Lopez, J, Trancucci, D, Stephenson, T, Chastain, K, Bahlis, N |
|---|---|
| Zdroj: | In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S515-S515 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|